US lawmakers reveal policy to curb collaboration with Chinese biotech - Pharmaceutical Technology

If enacted, BINSA would give lawmakers the right to monitor and restrict American companies from signing biotech and pharma-focused deals with Chinese entities. If enacted, lawmakers will hold the right to monitor and restrict American companies from signing certain deals with Chinese entities. Michigan lawmakers are looking to enact a policy that would restrict American dealmaking with Chinese biotech and pharma companies. Credit: OnePixelStudio / Shutterstock.com. Two bipartisan Michigan lawmakers have joined forces to debut new legislation that, if enacted, could significantly suppress dealmaking between Chinese and American biotech and pharma companies. Together, Republican John Moolenaar and Democrat Debbie Dingell…

Source: Pharmaceutical Technology